Crossref
journal-article
Elsevier BV
Toxicology and Applied Pharmacology (78)
References
27
Referenced
160
10.1021/ja00404a040
/ J. Am. Chem. Soc. / Avermectins. Structure determination by Albers-Schonberg (1981)10.1016/S0021-9258(19)74226-4
/ J. Biol. Chem. / Targeted disruption of the mousemdr1bmdr by Altuvia (1993)10.2307/3283936
/ J. Parasitol. / The mechanism of action of avermectins inCaenorhabditis elegans: by Arena (1995){'key': '10.1006/taap.1996.8086_TO968086C4', 'first-page': '485', 'article-title': 'Energy-dependent reduced drug binding as a mechanism of vinca alkaloid resistance in leukemic lymphoblasts', 'volume': '24', 'author': 'Beck', 'year': '1983', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Energy-dependent reduced drug binding as a mechanism of vinca alkaloid resistance in leukemic lymphoblasts by Beck (1983)10.1016/0006-2952(87)90198-5
/ Biochem. Pharmacol. / The cell biology of multiple drug resistance by Beck (1987){'key': '10.1006/taap.1996.8086_TO968086C6', 'series-title': 'Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells', 'author': 'Beck', 'year': '1991'}
/ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells by Beck (1991)10.1016/0092-8674(86)90595-7
/ Cell / Internal duplication and homology with bacterial transport proteins in themdr1 by Chen (1986)10.1128/MCB.9.9.3808
/ Mol. Cell. Biol. / Structure and expression of the humanMDR by Chin (1989){'key': '10.1006/taap.1996.8086_TO968086C9', 'series-title': 'Ivermectin and Abamectin', 'article-title': 'Metabolism and tissue residues', 'author': 'Chiu', 'year': '1989'}
/ Ivermectin and Abamectin / Metabolism and tissue residues by Chiu (1989)10.1073/pnas.86.2.695
/ Proc. Natl. Acad. Sci. USA / Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites by Cordon-Cardo (1989)10.1016/S0140-6736(94)91625-X
/ Lancet / Ivermectin for spasticity in spinal-cord injury by Costa (1994)10.1128/MCB.9.3.1346
/ Mol. Cell. Biol. / The three mouse multidrug resistance (mdr by Croop (1989){'key': '10.1006/taap.1996.8086_TO968086C13', 'first-page': '156', 'article-title': 'P-glycoprotein and multidrug resistance in cancer chemotherapy', 'volume': '16', 'author': 'Deuchars', 'year': '1989', 'journal-title': 'Semin. Oncol.'}
/ Semin. Oncol. / P-glycoprotein and multidrug resistance in cancer chemotherapy by Deuchars (1989)10.1128/MCB.7.11.4075
/ Mol. Cell. Biol. / Simultaneous expression of two P-glycoprotein genes in drug sensitive Chinese hamster ovary cells by Endicott (1987)10.1146/annurev.bi.58.070189.001033
/ Annu. Rev. Biochem. / The biochemistry of P-glycoprotein-mediated multidrug resistance by Endicott (1989){'key': '10.1006/taap.1996.8086_TO968086C16', 'series-title': 'Ivermectin and Abamectin', 'first-page': '131', 'article-title': 'Chemistry', 'author': 'Fisher', 'year': '1989'}
/ Ivermectin and Abamectin / Chemistry by Fisher (1989)10.1200/JCO.1987.5.9.1452
/ J. Clin. Oncol. / P-glycoprotein in human sarcoma: Evidence for multidrug resistance by Gerlach (1987)10.1093/jnci/81.2.116
/ J. Natl. Cancer Inst. / Expression of a multidrug resistance gene in human cancers by Goldstein (1989)10.1146/annurev.bi.62.070193.002125
/ Annu. Rev. Biochem. / Biochemistry of multidrug resistance mediated by the multidrug transporter by Gottesman (1993)10.1016/0092-8674(86)90594-5
/ Cell / Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins by Gros (1986)10.1038/227680a0
/ Nature / Cleavage of structural proteins during the assembly of the head of bacteriophage T4 by Laemmli (1970){'key': '10.1006/taap.1996.8086_TO968086C22', 'series-title': 'Ivermectin and Abamectin', 'first-page': '131', 'article-title': 'Toxicology', 'author': 'Lankas', 'year': '1989'}
/ Ivermectin and Abamectin / Toxicology by Lankas (1989)10.1016/S0889-8588(18)30097-2
/ Hematol. Oncol. Clin. NA / MDR expression in normal tissues—Pharmacological implications for the clinical use of P-glycoprotein inhibitors by Lum (1995)- MECTIZAN Program Notes, Issue 12, 1994, MECTIZAN Donation Program, One Copenhill, Atlanta, GA
10.1016/0092-8674(94)90212-7
/ Cell / Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs by Schinkel (1994)10.1172/JCI118214
/ J. Clin. Invest. / Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A by Schinkel (1995)10.1073/pnas.84.21.7735
/ Proc. Natl. Acad. Sci. USA / Cellular localization of the multidrug resistance gene product in normal human tissues by Thiebaut (1989)
Dates
Type | When |
---|---|
Created | 22 years, 11 months ago (Sept. 18, 2002, 6:01 p.m.) |
Deposited | 4 years, 4 months ago (May 3, 2021, 2:35 a.m.) |
Indexed | 1 month ago (Aug. 2, 2025, 12:14 a.m.) |
Issued | 28 years, 5 months ago (April 1, 1997) |
Published | 28 years, 5 months ago (April 1, 1997) |
Published Print | 28 years, 5 months ago (April 1, 1997) |
@article{Lankas_1997, title={P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity}, volume={143}, ISSN={0041-008X}, url={http://dx.doi.org/10.1006/taap.1996.8086}, DOI={10.1006/taap.1996.8086}, number={2}, journal={Toxicology and Applied Pharmacology}, publisher={Elsevier BV}, author={Lankas, George R. and Cartwright, Mark E. and Umbenhauer, Diane}, year={1997}, month=apr, pages={357–365} }